Challenges in anticancer drug R&D in China

Lancet Oncol. 2019 Feb;20(2):183-186. doi: 10.1016/S1470-2045(18)30865-9.
No abstract available

MeSH terms

  • Antineoplastic Agents*
  • Biomedical Research*
  • China
  • Drug Development*
  • Humans

Substances

  • Antineoplastic Agents